Disposition of Flavonoids for Personal Intake

[1]  Jian Shi,et al.  In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters , 2016, The AAPS Journal.

[2]  Jing He,et al.  Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies , 2016, Oncotarget.

[3]  Jian Shi,et al.  SGLT-1 Transport and Deglycosylation inside Intestinal Cells Are Key Steps in the Absorption and Disposition of Calycosin-7-O-β-d-Glucoside in Rats , 2016, Drug Metabolism and Disposition.

[4]  C. Prakash,et al.  Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions. , 2015, Nuclear receptor research.

[5]  I. Rietjens,et al.  Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites. , 2015, Biochemical pharmacology.

[6]  Liping Wang,et al.  Species‐ and gender‐dependent differences in the glucuronidation of a flavonoid glucoside and its aglycone determined using expressed UGT enzymes and microsomes , 2015, Biopharmaceutics & drug disposition.

[7]  L. Wang,et al.  The influence of ABCB1 polymorphism C3435T on the pharmacokinetics of silibinin , 2015, Journal of clinical pharmacy and therapeutics.

[8]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[9]  N. Pandita,et al.  Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes , 2015, Phytotherapy research : PTR.

[10]  N. Srinivas.  Biochanin A: Understanding the Complexities in the Paradoxical Drug–Drug Interaction Potential , 2015, European Journal of Drug Metabolism and Pharmacokinetics.

[11]  J. Camp,et al.  Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure–activity/property relationship-based approach in the study of bioavailability and bioactivity , 2015, Drug metabolism reviews.

[12]  E. Arenas.  Faculty Opinions recommendation of Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. , 2015 .

[13]  Liping Wang,et al.  Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids , 2015, The AAPS Journal.

[14]  Baojian Wu,et al.  Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay. , 2015, Molecular pharmaceutics.

[15]  V. Devanarayan,et al.  Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development , 2015, The AAPS Journal.

[16]  A. Dubala,et al.  Effect of Crude Extract of Eugenia jambolana Lam. on Human Cytochrome P450 Enzymes , 2014, Phytotherapy research : PTR.

[17]  I. Rietjens,et al.  A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats. , 2014, Biochemical pharmacology.

[18]  Yvonne S. Lin,et al.  Herb–Drug Interactions: Challenges and Opportunities for Improved Predictions , 2014, Drug Metabolism and Disposition.

[19]  Huidi Jiang,et al.  Metabolism of flavonoids in human: a comprehensive review. , 2014, Current drug metabolism.

[20]  C. Ren,et al.  Intakes of total and individual flavonoids by US adults , 2014, International journal of food sciences and nutrition.

[21]  K. Brouwer,et al.  An Experimental Approach To Evaluate the Impact of Impaired Transport Function on Hepatobiliary Drug Disposition Using Mrp2-Deficient TR– Rat Sandwich-Cultured Hepatocytes in Combination with Bcrp Knockdown , 2014, Molecular pharmaceutics.

[22]  J. Van Camp,et al.  Ultra(high)-pressure liquid chromatography-electrospray ionization-time-of-flight-ion mobility-high definition mass spectrometry for the rapid identification and structural characterization of flavonoid glycosides from cauliflower waste. , 2014, Journal of chromatography. A.

[23]  Zhonghe Chen,et al.  Computational studies of the regioselectivities of COMT-catalyzed meta-/para-O methylations of luteolin and quercetin. , 2014, The journal of physical chemistry. B.

[24]  L. Skálová,et al.  Modulatory Effects of Quercetin and Rutin on the Activity, Expression and Inducibility of CYP1A1 in Intestinal HCT‐8 Cells , 2013, Phytotherapy research : PTR.

[25]  J. Meigs,et al.  Higher Dietary Flavonol Intake Is Associated with Lower Incidence of Type 2 Diabetes12 , 2013, The Journal of nutrition.

[26]  A. Bode,et al.  Signal transduction and molecular targets of selected flavonoids. , 2013, Antioxidants & redox signaling.

[27]  Andrew Rowland,et al.  The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. , 2013, The international journal of biochemistry & cell biology.

[28]  Y. Nahmias,et al.  Flavonoids as dietary regulators of nuclear receptor activity. , 2013, Food & function.

[29]  A. Rodriguez-Mateos,et al.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. , 2013, Antioxidants & redox signaling.

[30]  S. Basu,et al.  Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells. , 2013, Molecular pharmaceutics.

[31]  S. Zeng,et al.  Luteolin is a rare substrate of human catechol-O-methyltransferase favoring a para-methylation. , 2013, Molecular nutrition & food research.

[32]  Juan Zhou,et al.  Simultaneous Determination of Sulfation and Glucuronidation of Flavones in FVB Mouse Intestine in Vitro and in Vivo , 2013, Journal of applied toxicology : JAT.

[33]  J. Marwick,et al.  Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Jianbo Xiao,et al.  Advance in Dietary Polyphenols as α-Glucosidases Inhibitors: A Review on Structure-Activity Relationship Aspect , 2013, Critical reviews in food science and nutrition.

[35]  R. Polimanti,et al.  Human genetic variation of CYP450 superfamily: analysis of functional diversity in worldwide populations. , 2012, Pharmacogenomics.

[36]  D. Ford,et al.  Polymorphisms in genes involved in the metabolism and transport of soy isoflavones affect the urinary metabolite profile in premenopausal women following consumption of a commercial soy supplement as a single bolus dose. , 2012, Molecular nutrition & food research.

[37]  Qiong Zhou,et al.  A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut. , 2012, Molecular pharmaceutics.

[38]  Taijun Yin,et al.  Breast Cancer Resistance Protein (ABCG2) Determines Distribution of Genistein Phase II Metabolites: Reevaluation of the Roles of ABCG2 in the Disposition of Genistein , 2012, Drug Metabolism and Disposition.

[39]  L. Carreto,et al.  Quercetin Protects Saccharomyces cerevisiae against Oxidative Stress by Inducing Trehalose Biosynthesis and the Cell Wall Integrity Pathway , 2012, PloS one.

[40]  M. Kampa,et al.  Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells. , 2012, The Journal of nutritional biochemistry.

[41]  Shi-ming Liu,et al.  UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes , 2012, Archives of Toxicology.

[42]  D. Nie,et al.  Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. , 2012, Biochemical pharmacology.

[43]  S. Wolffram,et al.  Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[44]  Juan Zhou,et al.  Systematic studies of sulfation and glucuronidation of 12 flavonoids in the mouse liver S9 fraction reveal both unique and shared positional preferences. , 2012, Journal of agricultural and food chemistry.

[45]  Xinxin Ding,et al.  Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[46]  J. Espín,et al.  Bioavailability of the Glucuronide and Sulfate Conjugates of Genistein and Daidzein in Breast Cancer Resistance Protein 1 Knockout Mice , 2011, Drug Metabolism and Disposition.

[47]  S. Basu,et al.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis. , 2011, Current drug metabolism.

[48]  Baojian Wu,et al.  Regioselective Glucuronidation of Flavonols by Six Human UGT1A Isoforms , 2011, Pharmaceutical Research.

[49]  Meng Chen,et al.  Role of Catechol-O-Methyltransferase in the Disposition of Luteolin in Rats , 2011, Drug Metabolism and Disposition.

[50]  Jeffrey M Peters,et al.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  S. Zeng,et al.  Structure–metabolism relationships for the glucuronidation of flavonoids by UGT1A3 and UGT1A9 , 2011, The Journal of pharmacy and pharmacology.

[52]  A. H. Tolson,et al.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. , 2010, Advanced drug delivery reviews.

[53]  S. Kuntz,et al.  Title: Chrysin Blocks Topotecan-induced Apoptosis in Caco-2 Cells in Spite of Inhibition of Abc-transporters Chrysin Blocks Topotecan-induced Apoptosis in Caco-2 Cells in Spite of Inhibition of Abc-transporters , 2022 .

[54]  Jianming Xu,et al.  Coactivators in PPAR-Regulated Gene Expression , 2010, PPAR research.

[55]  M. Hu,et al.  Breast Cancer Resistance Protein (BCRP) and Sulfotransferases Contribute Significantly to the Disposition of Genistein in Mouse Intestine , 2010, The AAPS Journal.

[56]  R. Singh,et al.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes. , 2010, Molecular pharmaceutics.

[57]  P. Blondeel,et al.  Disposition of soy isoflavones in normal human breast tissue. , 2010, The American journal of clinical nutrition.

[58]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[59]  Vikas Chandra,et al.  Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. , 2010, Annual review of physiology.

[60]  W. Karasov,et al.  Flavonoids Have Differential Effects on Glucose Absorption in Rats (Rattus norvegicus) and American Robins (Turdis migratorius) , 2010, Journal of Chemical Ecology.

[61]  C. Guillemette,et al.  UGT genomic diversity: beyond gene duplication , 2009, Drug metabolism reviews.

[62]  Jackie C Bloomer,et al.  Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie” , 2009, Drug Metabolism and Disposition.

[63]  V. Tam,et al.  Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides. , 2009, Molecular pharmaceutics.

[64]  A. Braune,et al.  The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. , 2009, Journal of NutriLife.

[65]  L. Moreno,et al.  Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. , 2009, Atherosclerosis.

[66]  T. Zhou,et al.  Sulfation of dietary flavonoids by human sulfotransferases , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[67]  C. Falany,et al.  Expression and Localization of Cytosolic Sulfotransferase (SULT) 1A1 and SULT1A3 in Normal Human Brain , 2009, Drug Metabolism and Disposition.

[68]  Piet Borst,et al.  Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol , 2009, Molecular Pharmacology.

[69]  D. Nie,et al.  Pregnane X receptor and its potential role in drug resistance in cancer treatment. , 2009, Recent patents on anti-cancer drug discovery.

[70]  M. Hu,et al.  Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein. , 2008, Journal of alternative and complementary medicine.

[71]  C. Klaassen,et al.  Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.

[72]  Z. Zuo,et al.  Intestinal and hepatic glucuronidation of flavonoids. , 2007, Molecular pharmaceutics.

[73]  Yuichi Sugiyama,et al.  Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens , 2007, Molecular Pharmacology.

[74]  E. Park,et al.  In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[75]  H. Wortelboer,et al.  The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. , 2007, Biochemical pharmacology.

[76]  Bradley L Urquhart,et al.  Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs , 2007, Journal of clinical pharmacology.

[77]  D. L. Bain,et al.  Nuclear receptor structure: implications for function. , 2007, Annual review of physiology.

[78]  S. Barnes,et al.  Differential biliary excretion of genistein metabolites following intraduodenal and intravenous infusion of genistin in female rats. , 2006, The Journal of nutrition.

[79]  M Miura,et al.  Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus. , 2006, International journal of clinical pharmacology and therapeutics.

[80]  V. Tam,et al.  Disposition of Flavonoids via Enteric Recycling: Structural Effects and Lack of Correlations between in Vitro and in Situ Metabolic Properties , 2006, Drug Metabolism and Disposition.

[81]  S. Higuchi,et al.  Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy , 2006, Expert opinion on drug metabolism & toxicology.

[82]  C. Klaassen,et al.  Induction of Rat UDP-Glucuronosyltransferases in Liver and Duodenum by Microsomal Enzyme Inducers That Activate Various Transcriptional Pathways , 2006, Drug Metabolism and Disposition.

[83]  Paul J. Harrison,et al.  Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond , 2006, Biological Psychiatry.

[84]  T. Ishikawa,et al.  Functional Validation of the Genetic Polymorphisms of Human ATP-Binding Cassette (ABC) Transporter ABCG2: Identification of Alleles That Are Defective in Porphyrin Transport , 2006, Molecular Pharmacology.

[85]  C. Falany,et al.  Pharmacogenetics of human cytosolic sulfotransferases , 2006, Oncogene.

[86]  Jennifer L. Martin,et al.  Human sulfotransferases and their role in chemical metabolism. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[87]  M. Negishi,et al.  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[88]  V. Tam,et al.  DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION , 2005, Drug Metabolism and Disposition.

[89]  C. V. Van Peteghem,et al.  Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. , 2005, Toxicology letters.

[90]  X. Jia,et al.  Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions. , 2005, Current drug metabolism.

[91]  S. Zeng,et al.  Involvement of P‐glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin , 2005, The Journal of pharmacy and pharmacology.

[92]  J. Schellens,et al.  Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Net Intestinal Uptake of Quercetin in Rats by Facilitating Apical Efflux of Glucuronides , 2005, Molecular Pharmacology.

[93]  X. Jia,et al.  Disposition of formononetin via enteric recycling: metabolism and excretion in mouse intestinal perfusion and Caco-2 cell models. , 2005, Molecular pharmaceutics.

[94]  Z. Zuo,et al.  Difference in absorption of the two structurally similar flavonoid glycosides, hyperoside and isoquercitrin, in rats. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[95]  T. Vree,et al.  Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. , 2005, The Journal of nutrition.

[96]  C. Falany,et al.  Regulation of Human Hepatic Hydroxysteroid Sulfotransferase Gene Expression by the Peroxisome Proliferator-Activated Receptor α Transcription Factor , 2005, Molecular Pharmacology.

[97]  Yuichi Sugiyama,et al.  Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen , 2005, Molecular Pharmacology.

[98]  Mustafa Usta,et al.  Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. , 2005, Biochemical pharmacology.

[99]  Huimin Lin,et al.  Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model , 2005, Cancer Chemotherapy and Pharmacology.

[100]  M. Egan,et al.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.

[101]  Vincent Laudet,et al.  Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.

[102]  W. Tolleson,et al.  Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover). , 2004, Journal of agricultural and food chemistry.

[103]  X. Jia,et al.  Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates , 2004, Journal of Pharmacology and Experimental Therapeutics.

[104]  M. Morris,et al.  Combined Effects of Multiple Flavonoids on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport , 2004, Pharmaceutical Research.

[105]  Y. Sugimoto,et al.  Phytoestrogens/Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance , 2004, Cancer Research.

[106]  G. Williamson,et al.  A critical review of the bioavailability of glucosinolates and related compounds. , 2004, Natural product reports.

[107]  R. Hamilton.  Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR , 2004 .

[108]  J. Miners,et al.  Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches. , 2004, Annual review of pharmacology and toxicology.

[109]  K. Bock,et al.  Coordinate Regulation of Drug Metabolism by Xenobiotic Nuclear Receptors: UGTs Acting Together with CYPs and Glucuronide Transporters , 2004, Drug metabolism reviews.

[110]  T. Walle,et al.  Induction of UDP-Glucuronosyltransferase UGT1A1 by the Flavonoid Chrysin in Caco-2 Cells—Potential Role in Carcinogen Bioinactivation , 2001, Pharmaceutical Research.

[111]  U. Christians,et al.  Grapefruit Juice Activates P-Glycoprotein-Mediated Drug Transport , 1999, Pharmaceutical Research.

[112]  K. Muro,et al.  Regioselective monosulfation and disulfation of the phytoestrogens daidzein and genistein by human liver sulfotransferases. , 2004, Drug metabolism and pharmacokinetics.

[113]  T. Walle,et al.  Induction of UDP-Glucuronosyl-Transferase by the Flavonoids Chrysin and Quercetin in Caco-2 Cells , 2004, Pharmaceutical Research.

[114]  C. Handschin,et al.  Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.

[115]  Huimin Lin,et al.  Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model , 2003, Journal of Pharmacology and Experimental Therapeutics.

[116]  W. Hauck,et al.  Exposure‐Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice , 2003, Journal of clinical pharmacology.

[117]  C. Klaassen,et al.  NUCLEAR RECEPTOR, PREGNANE X RECEPTOR, IS REQUIRED FOR INDUCTION OF UDP-GLUCURONOSYLTRANSFERASES IN MOUSE LIVER BY PREGNENOLONE-16α-CARBONITRILE , 2003 .

[118]  C. Guillemette,et al.  The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome Proliferator-activated Receptor α and γ Target Gene* , 2003, The Journal of Biological Chemistry.

[119]  G. Williamson,et al.  Absorption of quercetin-3-glucoside and quercetin-4'-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. , 2003, Biochemical pharmacology.

[120]  Leslie Z Benet,et al.  In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model , 2003, Journal of Pharmacology and Experimental Therapeutics.

[121]  Wen Xie,et al.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[122]  Huimin Lin,et al.  Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition , 2003, Journal of Pharmacology and Experimental Therapeutics.

[123]  G. Williamson,et al.  Hydrolysis by lactase phlorizin hydrolase is the first step in the uptake of daidzein glucosides by rat small intestine in vitro , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[124]  C. Klaassen,et al.  Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[125]  J. Arnason,et al.  In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[126]  C. Guillemette,et al.  The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. , 2003, The Journal of biological chemistry.

[127]  B. Ring,et al.  Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[128]  D. Moore,et al.  Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR , 2002, Science.

[129]  R. Tukey,et al.  Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. , 2002, Molecular pharmacology.

[130]  C. Falany,et al.  Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[131]  Y. Miki,et al.  C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. , 2002, Molecular cancer therapeutics.

[132]  T. Walle,et al.  Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[133]  Karsten Kristiansen,et al.  Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. , 2002, The Biochemical journal.

[134]  Ming Hu,et al.  Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[135]  D. Moore,et al.  Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response , 2002, The Pharmacogenomics Journal.

[136]  J. Lehmann,et al.  Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. , 2002, Molecular pharmacology.

[137]  B. M. Forman,et al.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.

[138]  M. J. van de Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[139]  A. Aro,et al.  Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. , 2001, The Journal of nutrition.

[140]  G. Dresser,et al.  Grapefruit‐felodipine interaction: Effect of unprocessed fruit and probable active ingredients , 2000, Clinical pharmacology and therapeutics.

[141]  M. Hunt,et al.  The Peroxisome Proliferator-activated Receptor α (PPARα) Regulates Bile Acid Biosynthesis* , 2000, The Journal of Biological Chemistry.

[142]  R. Walgren,et al.  Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1. , 2000, The Journal of pharmacology and experimental therapeutics.

[143]  T. Walle,et al.  Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[144]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[145]  T. Walle,et al.  Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[146]  B. Neuschwander‐Tetri,et al.  Humanized xenobiotic response in mice expressing nuclear receptor SXR , 2000, Nature.

[147]  M. Kikuchi,et al.  Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. , 2000, The Journal of nutrition.

[148]  T. Tsuruo,et al.  Effect of bioflavonoids on vincristine transport across blood-brain barrier. , 2000, European journal of pharmacology.

[149]  P. Stehle,et al.  Absorption and metabolism of genistein in isolated rat small intestine. , 2000, The Journal of nutrition.

[150]  T. Badger,et al.  Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[151]  G. Williamson,et al.  Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase , 2000, FEBS letters.

[152]  B. Shan,et al.  FXR, a bile acid receptor and biological sensor. , 2000, Trends in cardiovascular medicine.

[153]  M. Hunt,et al.  The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis. , 2000, The Journal of biological chemistry.

[154]  L. Moore,et al.  The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. , 2000, Molecular endocrinology.

[155]  P. Männistö,et al.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.

[156]  H. Ciolino,et al.  Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. , 1999, The Biochemical journal.

[157]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[158]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[159]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[160]  A. Fryer,et al.  Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. , 1999, The Biochemical journal.

[161]  D. Peet,et al.  The LXRs: a new class of oxysterol receptors. , 1998, Current opinion in genetics & development.

[162]  G Williamson,et al.  Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β‐glucosidase activity , 1998, FEBS letters.

[163]  J. Phang,et al.  Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. , 1998, Cancer research.

[164]  R. Hammer,et al.  Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.

[165]  A. Gescher,et al.  Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[166]  R. Weintraub,et al.  Drug Interactions with Grapefruit Juice , 1997, Clinical pharmacokinetics.

[167]  S. Barnes,et al.  Intestinal uptake and biliary excretion of the isoflavone genistein in rats. , 1997, The Journal of nutrition.

[168]  Timothy M. Willson,et al.  Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway* , 1997, The Journal of Biological Chemistry.

[169]  F. Gonzalez,et al.  Targeted Disruption of the Peroxisome Proliferator—Activated Receptor α Gene, PPARα , 1996, Annals of the New York Academy of Sciences.

[170]  K. Griffin,et al.  Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[171]  A. Wilson,et al.  Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[172]  W. Wahli,et al.  Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. , 1996, Endocrinology.

[173]  T. Walle,et al.  Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase. , 1995, Biochemical pharmacology.

[174]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[175]  K. Umesono,et al.  LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.

[176]  L. Marchand,et al.  CYP1A1 genetic polymorphisms and in situ colorectal cancer. , 1994, Cancer research.

[177]  D. Moore,et al.  A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements , 1994, Molecular and cellular biology.

[178]  G. Siest,et al.  The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. , 1991, DNA and cell biology.

[179]  D. Russell,et al.  Structure of the rat gene encoding cholesterol 7α-hydroxylase , 1990 .

[180]  D. Russell,et al.  Structure of the rat gene encoding cholesterol 7 alpha-hydroxylase. , 1990, Biochemistry.

[181]  Smith Ds,et al.  Effects of flavonoids on the metabolism of xenobiotics. , 1986 .

[182]  M. Huang,et al.  Effects of flavonoids on the metabolism of xenobiotics. , 1986, Progress in clinical and biological research.

[183]  J. Müntzing,et al.  Pilot study on the growth inhibition by estramustine phosphate (Estracyt) of rat mammary tumours sensitive and insensitive of oestrogen. , 2009, Acta pharmacologica et toxicologica.